Improving the Regulatory Review Process ILO December 10–11

December 10–11

die sich mit dem Bereich Marke und Markenwert beschäftigen

12 and 13 were written by-Prof

heutiger Diskussionsstand und Entwürfe zu einer gesetzlichen Regelung

vorbereitet und zugleich voll Spannung auf das Kommende im Epos harren kann

Improving the Regulatory Review Process ILO December 10–11Regulatory review is the last major development hurdle that must be passed by a new medicine before it reaches the market. At a time when pharmaceutical companies are reviewing their R&D strategies, and attempting to reduce drug development times, it is extremely important that the review process is made as efficient as possible. The 11th CMR Workshop, held in September 1995, provided the opportunity for regulatory authority and industry personnel